Akorn Incorporated

Type: Company

Name: Akorn Incorporated

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Post Earnings Update: Akorn Has Climbed 3.4% Higher in Past Week (AKRX)

A week ago on May 7th, 2013 Akorn (NASDAQ:AKRX) reported earnings and analysts, on average, expected earnings of $0.14 on sales of $74.1 million. Akorn actually reported earnings of $0.13 per share on sales of $73.9 million, missing EPS estimates by $0.01 ... [Published Comtex SmarTrend - May 20 2013]

Entities: Akorn Incorporated, Stocks, watchlist

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Akorn reports higher Q1 net income, provides outlook for 2013

Akorn, Inc., a provider of diagnostic and therapeutic ophthalmic pharmaceuticals, has reported that net income for the first quarter ended March 31, 2013 was $10.84 million, or $0.10 per diluted share, compared to $3.11 million, or $0.03 per diluted share, ... [Published Individual.com - May 20 2013]

Entities: Akorn Incorporated, Ophthalmic, Gross Profit Margin, Diagnostic

First reported May 19 2013 - Updated May 19 2013 - 1 reports

Post Earnings Update: Akorn Has Climbed...

11 days ago, on May 7th, 2013, Akorn (NASDAQ:AKRX) reported its earnings. Analysts, on average, expected earnings of $0.14 per share on sales of $74.1 million. Akorn actually reported earnings of $0.13 per share on sales of $73.9 million, missing EPS ... [Published Financial News Network online - May 19 2013]

Entities: Akorn Incorporated, Ophthalmic, Moving Average, Rheumatology, Ophthalmology

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Post Earnings Update: Akorn Has Climbed 3.4% Higher in Past Week (AKRX)

(Financial News Network On) 11 days ago, on May 7th, 2013, Akorn (NASDAQ:AKRX) reported its earnings. Analysts, on average, expected earnings of $0.14 per share on sales of $74.1 million. Akorn actually reported earnings of $0.13 per share on sales ... [Published Individual.com - May 18 2013]

Entities: Akorn Incorporated

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Patterson-Jarrett, Tia S.

DECATUR â Tia S. Patterson-Jarrett, 20, of Decatur departed this life Tuesday, May 14, 2013 at Barnes-Jewish Hospital, St. Louis, MO.Tia was born on August 10, 1992 in Decatur, Illinois the daughter of Dexter and Mia (Johnson) Jarrett. She was a 2010 ... [Published Herald & Review - May 16 2013]

Entities: Decatur (Illinois, United States), Abby Johnson, Indianapolis, Karen White, George Johnson

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Akorn Makes a Move: Up 1.4%

One of today's stocks on the move is Akorn (NASDAQ:AKRX), up 1.4% to $14.47. The S&P is currently trading 0.7% higher to 1,646 and the Dow Jones Industrial Average is trading 0.5% higher to 15,160.Potential upside of 16.5% exists for Akorn, based on a ... [Published Financial News Network online - May 14 2013]

Entities: Akorn Incorporated, Ophthalmic, Moving Average, Rheumatology, Ophthalmology

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Stock Investors Bid Up Shares of Akorn...

Akorn (NASDAQ:AKRX), a company whose shares are moving quickly, is trading 1.9% higher to $14.26. The Dow is trading fractionally lower to 15,060 and the S&P is currently trading fractionally higher to 1,627.Potential upside of 18.2% exists for Akorn, ... [Published Financial News Network online - May 10 2013]

Entities: Akorn Incorporated, Ophthalmic, Stocks, fractionation

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Vitamin Shoppe, Fossil, Akorn are big movers

Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market ... [Published Omaha World-Herald - May 07 2013]

Entities: Akorn Incorporated, Vitamin Shoppe Inc, Fossil

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Akorn's CEO Discusses Q1 2013 Results - Earnings Call Transcript

10:00 AM ETOperatorPlease standby. We’re about to begin. Good morning, and thank you for joining the Akorn Inc’s 2013 First Quarter Conference Call. If you have not yet had a chance to read the earnings release, you may access it through the Investor ... [Published Seeking Alpha - May 07 2013]

Entities: Akorn Incorporated, Research & Development, Xalatan

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Akorn, Inc. (AKN) Reports First Quarter 2013 Financial Results

Staying up-to-date has never been simpler. Sign up for the today! Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for its first quarter ended March 31, 2013. Raj Rai, Chief Executive Officer, commented, ... [Published BioSpace - May 07 2013]

Entities: Akorn Incorporated, Manufacturing

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Akorn 1Q profit soars but 2013 forecast falls

LAKE FOREST, Ill. --Akorn Inc.'s first quarter earnings soared, as the generic drugmaker recorded revenue gains from new and established products and its India business.But the results missed Wall Street expectations and the Lake Forest, Ill., company ... [Published South Carolina Enquirer-Herald - May 07 2013]

Entities: Akorn Incorporated, Akron (Ohio, United States), India

First reported May 07 2013 - Updated May 07 2013 - 2 reports

Akorn Reports First Quarter 2013 Financial Results

- Reports Record Revenue of $73.9 million and Adjusted EPS of $0.13 -LAKE FOREST, Ill.--(BUSINESS WIRE)-- Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for its first quarter ended March 31, 2013.Raj ... [Published Street Insider - May 07 2013]

Entities: Akorn Incorporated, EBITDA, Research & Development, Clindamycin Phosphate

Quotes

Raj Rai, CEO, commented, "We are pleased with our first quarter results although we were behind in the launches of certain products that were approved late last year due to capacity constraints with our contract manufacturing partners as well as market challenges. We expect resolution sometime in the second half of this year. We are also excited about the establishment of our new R&D center in Vernon Hills, Illinois. The new center, with its added capacities and capabilities, will make it possible for us to file 35 to 40 ANDAs with the USFDA from our US and India facilities starting next year, which is the cornerstone of our long term growth strategy."

Akorn reports higher Q1 net income, provides outlook for 2013 [Published Individual.com - May 20 2013]

New Drugs for Lupus: State of the Art (1:30-3:00 PM June 13th), "Effects of Blisibimod, an Inhibitor of B-Cell Activating Factor, on Markers of Renal Disease in Patients with SLE."

Anthera Announces Additional Data from Phase 2b PEARL-SC; pSivida Announces Commercial Launch of ... [Published BioMedReports - May 08 2013]

"We believe that this announcement is causing some jitters on the Street today" Pantginis said in a note, adding that he does not believe there was a reason for concern

MARKET PULSE-Aruba, Nautilus, Ducommun, Ruckus, MercadoLibre, Pike [Published CNBC - May 07 2013]

...Raj Rai, Chief Executive Officer, commented, "We are pleased with our first quarter results although we were behind in the launches of certain products that were approved late last year due to capacity constraints with our contract manufacturing partners as well as market challenges. Help employers find you! Check out all the jobs and ."

Akorn, Inc. (AKN) Reports First Quarter 2013 Financial Results [Published BioSpace - May 07 2013]

More Content

sort by: Date \| Relevance
Post Earnings Update: Akorn Has Climbed 3.4% Hi... [Published Comtex SmarTrend - May 20 2013]
Akorn reports higher Q1 net income, provides ou... [Published Individual.com - May 20 2013]
Post Earnings Update: Akorn Has Climbed... [Published Financial News Network online - May 19 2013]
Post Earnings Update: Akorn Has Climbed 3.4% Hi... [Published Individual.com - May 18 2013]
Patterson-Jarrett, Tia S. [Published Herald & Review - May 16 2013]
Akorn Makes a Move: Up 1.4% [Published Financial News Network online - May 14 2013]
COGENTIN (Benztropine Mesylate) Injection [Oak ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Stock Investors Bid Up Shares of Akorn... [Published Financial News Network online - May 10 2013]
Today's Research on DCTH, AKRX, ASTX, BMRN, and... [Published Individual.com - May 10 2013]
LATANOPROSTsolution/ Drops [Akorn, Inc.] [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
Form 4 AKORN INC For: May 03 Filed by: KAPOOR J... [Published Street Insider - May 08 2013]
Akorn Inc posts higher non-GAAP adjusted net in... [Published Zecco - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: Silverbe... [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: BONACCOR... [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: Graves A... [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: RAI RAJAT [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: Sabat Jo... [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: Dick Tim... [Published Street Insider - May 08 2013]
Anthera Announces Additional Data from Phase 2b... [Published Equities.com - May 08 2013]
Anthera Announces Additional Data from Phase 2b... [Published BioMedReports - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: ABRAMOWI... [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: MEYER ST... [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: Tambi Brian [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: WEINSTEI... [Published Street Insider - May 08 2013]
Form 4 AKORN INC For: May 03 Filed by: KUTINSKY... [Published Street Insider - May 07 2013]
Form 4 AKORN INC For: May 03 Filed by: JOHNSON ... [Published Street Insider - May 07 2013]
Vitamin Shoppe, Fossil, Akorn are big movers [Published Omaha World-Herald - May 07 2013]
U.S./Canada daily earnings hits & misses May 7 ... [Published Globe and Mail - May 07 2013]
Akorn 1Q profit soars but 2013 forecast falls [Published Naperville Business Ledger - May 07 2013]
Vitamin Shoppe, Fossil, Akorn are big movers [Published Marin Independent Journal - May 07 2013]

Blogs

sort by: Date \| Relevance
COGENTIN (Benztropine Mesylate) Injection [Oak ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013] Updated Date: May 10, 2013 EST ...
LATANOPROSTsolution/ Drops [Akorn, Inc.] [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013] Updated Date: May 2, 2013 EST ...
Potential Akorn (AKRX) Trade Has $13.80 Breakeven [Published MarketIntelligenceCenter.com - May 01 2013] Akorn Inc. (NASDAQ: AKRX) closed Tuesday's trading session at $15.05. In the past year, the stock has hit a 52-week low of $11.19 and 52-week high of $16.87. Akorn (AKRX) stock has been showing support around $14.79 and resistance in the $15.35 range. ...
CLINDAMYCIN (Clindamycin Phosphate) Injection [... [Published DailyMed Drug Label Updates for the last seven ... - Apr 08 2013] Updated Date: Apr 8, 2013 EST ...
Akorn (AKRX) Showing Bullish Technicals With Su... [Published MarketIntelligenceCenter.com - Apr 04 2013] Akorn Inc. (NASDAQ: AKRX) closed Wednesday's trading session at $13.41. In the past year, the stock has hit a 52-week low of $10.53 and 52-week high of $16.87. Akorn (AKRX) stock has been showing support around $13.11 and resistance in the $14.01 range. ...

Press Releases

sort by: Date \| Relevance
Akorn Reports First Quarter 2013 Financial Results [Published Business Wire Science: Science News - May 07 2013]
Akorn Reports First Quarter 2013 Financial Results [Published Business Wire Health News - May 07 2013]
Akorn, Inc. Announces First Quarter 2013 Earnin... [Published PR Newswire: Health - Apr 03 2013]
Before the Bell Scans of Mylan, Forest Laborato... [Published PR Newswire: Health - Mar 08 2013]
Akorn Reports 2012 Fourth Quarter and Year-End ... [Published EON Health & Medicine - Feb 26 2013]